多核苷酸多态性分析在异基因造血干细胞移植后嵌合检测中的应用
该研究建立基于高通量测序的多核苷酸多态性分析(MNPseq)用于异基因造血干细胞移植后嵌合状态检测,通过模拟嵌合样本和临床移植后样本与STR法、融合基因定量检测及流式细胞术微小残留病检测对比验证。结果显示MNPseq准确性和敏感性均优于STR法,敏感性达0.01%,较STR法敏感约100倍,可进一步区分STR完全嵌合的42份样本,并能纠正STR影子峰所致假阳性及检测缺乏移植前信息的嵌合体标本。
要点
- MNPseq敏感性达0.01%,较STR法敏感约100倍,准确性和敏感性均优于STR法。
- MNPseq可进一步区分STR完全嵌合的42份样本,经Cutoff值校正后与融合基因定量检测结果相关。
- MNPseq可纠正STR影子峰所致假阳性,并可检测缺乏供者/患者移植前信息的嵌合体标本。
核心结论
- 基于高通量测序的MNPseq分析是一种更加准确和敏感的嵌合体检测方法,解决了缺乏移植前信息无法检测嵌合体的问题,具有极高的临床应用价值。
研究设计与样本
- 筛选100个MNP片段,采用高通量测序技术,通过模拟嵌合样本和临床移植后样本进行验证。
- 与STR法、融合基因定量检测和流式细胞术微小残留病检测进行对比,验证方法的准确性和敏感性。
主要发现
- MNPseq的准确性和敏感性均优于STR法,敏感性为0.01%,较STR法敏感约100倍。
- MNPseq可以进一步区分STR完全嵌合的42份样本,且经Cutoff值校正后与融合基因定量检测结果相关。
- MNPseq可以纠正因为影子峰所造成的STR法的假阳性。
- MNPseq可以用于检测缺乏供者和(或)患者移植前信息的嵌合体标本。
临床怎么用
- MNPseq可用于异基因造血干细胞移植后嵌合状态的更准确和敏感检测。
- MNPseq可纠正STR影子峰所致假阳性,并可用于缺乏移植前信息的嵌合体标本检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To establish a new method for chimerism analysis after allogeneic hematopoietic stem cell transplantation by using multiple nucleotide polymorphism sequencing (MNPseq) , and to explore its feasibility and superiority. Methods: One hundred MNP fragments were screened and chimeric analysis was performed by high-throughput sequencing technology. The accuracy and sensitivity of the method were verified by simulating chimeric samples and post-transplant samples and comparing them with short tandem repeat (STR) analysis, fusion gene quantitative detection and flow cytometry for minimal residual disease. Results: The accuracy and sensitivity of MNPseq were better than those of STR, in which the sensitivity could reach 0.01%, about 100 times more sensitive than STR. MNPseq could further distinguish 42 STR fully chimeric samples, and after corrected by cutoff value, it was correlated with the quantitative detection of fusion gene. MNPseq could correct false positive of STR caused by the shadow peak, and could be used to detect chimeric samples lacking pre-transplant information from donors and recipients. Conclusion: MNPseq analysis based on high-throughput sequencing is a more accurate and sensitive chimerism detection method, and it solves the problem that chimerism cannot be detected due to the lack of pre-transplant information, which has extremely high clinical application value. 目的: 建立一种利用多核苷酸多态性高通量测序(MNPseq)分析异基因造血干细胞移植后嵌合状态的新方法,并探讨其可行性及优越性。 方法: 筛选100个MNP片段,采用高通量测序技术,通过模拟嵌合样本和临床移植后样本,与STR法、融合基因定量检测和流式细胞术微小残留病检测进行对比,验证方法的准确性和敏感性。 结果: MNPseq的准确性和敏感性均优于STR法,其中敏感性为0.01%,较STR法敏感约100倍;MNPseq可以进一步区分STR完全嵌合的42份样本,且经Cutoff值校正后,与融合基因定量检测结果相关;MNPseq可以纠正因为影子峰所造成的STR法的假阳性,并且可以用于检测缺乏供者和(或)患者移植前信息的嵌合体标本。 结论: 基于高通量测序的MNPseq分析是一种更加准确和敏感的嵌合体检测方法,而且解决了缺乏移植前信息无法检测嵌合体的问题,具有极高的临床应用价值。.
引用
- Lyu XD, Zou Z, Peng H, et al. [Application of multiple nucleotide polymorphism analysis in chimerism detection after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31495133. doi:10.3760/cma.j.issn.0253-2727.2019.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。